Facebook
Twitter
LinkedIn
ForwardPediatric Pharmacy Pearls: PICU/NICU Survival Guide and Developmental Pharmacokinetics
October 19, 2020
The purpose of this activity is to provide pediatric-focused education for pharmacists designed to increase knowledge and improve patient care skills.
Target Audience
- Pharmacists
Learning Objectives
- Discuss potentially toxic preservatives or excipients requiring cautious use or avoidance in pediatric or neonatal intensive care units
- Assess sedation regimens for taper readiness
- Explain factors affecting pharmacokinetic principles
- Illustrate the differences in pharmacokinetic parameters from neonates to adolescents
Additional Information
| Attachment | Size |
|---|---|
 Helpful Tips for Users.pdf | 157.72 KB |
 Information for CE Credit - Pediatric Pharmacy Pearls 10.19.2020.docx | 125.07 KB |
Live via webinar
United States
Planning committee members and presenters have nothing to disclose
Planning committee members
Sybil Thomas, PharmD, MBA
Senior Director
Vizient
Kristin Heid Wheatley, PharmD, BCOP
Clinical Pharmacy Specialist, Pediatric Oncology and Infectious Diseases
Lehigh Valley Health Network
Course reviewer
Sybil Thomas, PharmD, MBA
Senior Director
Vizient
Presenters
Lauryn Smelser, PharmD
Pediatric Clinical Pharmacist
University of Iowa Stead Family Children’s Hospital
Joshua Nachreiner, PharmD
PGY-2 Clinical Pediatric Pharmacist Resident
UW Health / American Family Children’s Hospital
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statements:
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-20-183-L01-P
Available Credit
- 1.00 ACPE Pharmacist